WHO ICTRP trial
RAndomized Comparison of efficacy and safety of lipid-lowerING with statin…
KCT0002910 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0002910 |
|---|---|
| Public title | RAndomized Comparison of efficacy and safety of lipid-lowerING with statin monotherapy versus statin/ezetimibe combination for high-risk cardiovascular diseases (RACING trial) |
| Scientific title | RAndomized Comparison of efficacy and safety of lipid-lowerING with statin monotherapy versus statin/ezetimibe combination for high-risk cardiovascular diseases (RACING trial) |
| Primary sponsor | Yonsei University Health System, Severance Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase4 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the circulatory system |
| Interventions | Drug : 1. High-intensity statin monotherapy (Statin monotherapy) Subjects will start rosuvastatin 20 mg a day for 3years irrespective of previous lipid-lowering treatment or LDL-cholesterol level as current US guideline. 2. Statin plus… |
| Registration date | Jun 2, 2018 |
| Target size | 3780 |
| Secondary IDs | NCT03044665 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: